Get the Stockscreener App
512.69
0.90%
4.59
After Hours:
512.18
-0.51
-0.10%
Overview
News
Price History
Option Chain
Financials
Why TMO Down?
Discussions
Forecast
Stock Split
Dividend History
Thermo Fisher Scientific Inc stock is traded at $512.69, with a volume of 1.68M.
It is up +0.90% in the last 24 hours and down -9.29% over the past month.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
See More
Previous Close:
$508.10
Open:
$510
24h Volume:
1.68M
Relative Volume:
0.79
Market Cap:
$192.62B
Revenue:
$44.56B
Net Income/Loss:
$6.73B
P/E Ratio:
28.90
EPS:
17.7391
Net Cash Flow:
$6.29B
1W Performance:
-0.19%
1M Performance:
-9.29%
6M Performance:
+4.74%
1Y Performance:
-0.75%
1-Day Range:
$508.95
$517.65
1-Week Range:
$493.37
$521.28
52-Week Range:
$385.46
$643.99
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Name
Thermo Fisher Scientific Inc
Sector
Industry
Phone
(781) 622-1000
Address
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
512.69 | 190.90B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
204.73 | 144.26B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
648.70 | 50.60B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
120.54 | 33.67B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
319.04 | 30.62B | 3.17B | 642.63M | 516.49M | 10.77 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-11-25 | Upgrade | Citigroup | Neutral → Buy |
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Dec-01-25 | Upgrade | HSBC Securities | Hold → Buy |
| Sep-11-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-19-25 | Initiated | William Blair | Outperform |
| Jul-24-25 | Downgrade | HSBC Securities | Buy → Hold |
| Jul-11-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Jul-09-25 | Downgrade | UBS | Buy → Neutral |
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Mar-18-24 | Resumed | Citigroup | Neutral |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Jan-08-24 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-18-23 | Initiated | HSBC Securities | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-26-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-25-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Sep-06-23 | Resumed | Citigroup | Buy |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| Jul-19-23 | Reiterated | Robert W. Baird | Outperform |
| Jul-13-23 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-04-23 | Reiterated | Barclays | Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-27-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-26-22 | Resumed | Barclays | Overweight |
| Oct-20-21 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Mar-18-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-08-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Sep-14-20 | Initiated | Morgan Stanley | Overweight |
| Aug-20-20 | Resumed | JP Morgan | Overweight |
| Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Jul-07-20 | Reiterated | Needham | Buy |
| Apr-23-20 | Reiterated | Needham | Buy |
| Jan-31-20 | Reiterated | Needham | Buy |
| Jan-22-20 | Initiated | Credit Suisse | Neutral |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Buy |
| Jul-25-19 | Reiterated | Needham | Buy |
| Jul-16-19 | Downgrade | Needham | Strong Buy → Buy |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| May-23-19 | Reiterated | Needham | Strong Buy |
| Apr-22-19 | Reiterated | Needham | Strong Buy |
| Apr-16-19 | Reiterated | BofA/Merrill | Buy |
View All
Thermo Fisher Scientific Inc Stock (TMO) Latest News
Thermo Fisher expands immunodiagnostics operations with new distribution and labeling centre in Uppsala - BioSpectrum Asia
Thermo Fisher microscopes: Why labs are fighting to get them - AD HOC NEWS
Thermo Fisher’s Candida Auris Test Launch Meets Valuation And Momentum Crossroads - simplywall.st
Marc Casper sells 5,000 TMO shares via Fidelity (TMO) - Stock Titan
Thermo Fisher Scientific Expands Immunodiagnostics Operations with New Distribution and Labeling Center in Uppsala - WebWire
Teachers Retirement System of The State of Kentucky Lowers Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Picton Mahoney Asset Management Takes $17.01 Million Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Dimensional Fund Advisors LP Sells 24,687 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
News | Biotech giant recommits to major Wisconsin hub despite cuts across US office portfolio - CoStar
[Latest] Global Microplate Systems Market Size/Share Worth USD 2.88 Billion by 2035 at a 10.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
Thermo Fisher Scientific Inc., a global leader in scientific services, recently announced a major investment plan. - Bitget
Petaluma industrial real estate pricing trends downward amid vacancies - The Press Democrat
[144] THERMO FISHER SCIENTIFIC INC. SEC Filing - Stock Titan
Thermo Fisher at Raymond James Conference: Strategic Growth Insights - Investing.com
TMO (NYSE: TMO) Form 144 lists multiple vested restricted-share lots for sale - Stock Titan
PacBio and DNAstack Collaborate on Global HiFi Genome Network Hub - TradingView
Victory Capital Management Inc. Has $407.11 Million Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher (NYSE: TMO) HR chief disposes shares to cover tax liability - Stock Titan
Thermo Fisher (NYSE: TMO) CEO reports tax-withholding share transfers - Stock Titan
Novartis settles with Henrietta Lacks' estate over use of her cancer cells to advance medicine - PBS
Thermo Fisher Scientific Inc. stock falls Monday, underperforms market - MarketWatch
Thermo Fisher (TMO) accounting chief reports tax-withholding stock dispositions - Stock Titan
Thermo Fisher (TMO) EVP reports Form 4 tax-withholding stock dispositions - Stock Titan
Thermo Fisher (NYSE: TMO) COO disposes shares to cover tax obligations - Stock Titan
Thermo Fisher (NYSE: TMO) CFO reports tax-withholding of company shares - Stock Titan
Thermo Fisher (NYSE: TMO) EVP covers taxes with share disposal - Stock Titan
Thermo Fisher (NYSE: TMO) EVP uses shares to cover tax obligations - Stock Titan
Thermo Fisher Scientific: Recovery In Life Sciences Solutions (NYSE:TMO) - Seeking Alpha
AIM Collaborates with Thermo Fisher for Phase 3 Trial of Amplige - GuruFocus
Thermo Fisher Scientific Launches New Color-Based (Chromogenic) Culture Media to Help Detect Candida Infections Faster*, Including Drug-Resistant Candida auris - Fox21Online
Thermo Fisher Scientific Inc (TMO) Stock Analysis: Potential 27.89% Upside Amid Robust Growth and Strategic Positioning - DirectorsTalk Interviews
Thermo Fisher Scientific Inc. $TMO is Waverton Investment Management Ltd's 7th Largest Position - MarketBeat
Thermo Fisher Scientific Inc. $TMO Holdings Lifted by Fairtree Asset Management Pty Ltd - MarketBeat
Thermo Fisher Scientific Inc. $TMO is London & Capital Asset Management Ltd's 6th Largest Position - MarketBeat
Davis R M Inc. Sells 2,494 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
American Century Companies Inc. Buys 170,888 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Launches TacroType Test As Shares Trade Below Targets - Yahoo Finance
Thermo Fisher Scientific Inc. $TMO Shares Acquired by Aviso Financial Inc. - MarketBeat
Accredited Wealth Management LLC Reduces Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher’s TacroType Test Highlights Push Into Targeted Transplant Genomics - simplywall.st
Harvest Portfolios Group Inc. Sells 4,403 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Stock Holdings Decreased by Huntington National Bank - MarketBeat
Intech Investment Management LLC Sells 5,099 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
How Does Thermo Fisher Scientific Stock Stack Up Against Its Peers? - Trefis
Artisan Partners Limited Partnership Grows Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific (NYSE:TMO) Upgraded at Wall Street Zen - MarketBeat
Henrietta Lacks: Family of woman whose cells were 'stolen' settles second lawsuit - BBC
Thermo Fisher (TMO) SVP and General Counsel receives new stock and option awards - Stock Titan
Thermo Fisher (NYSE: TMO) CEO receives new stock and option awards - Stock Titan
Thermo Fisher’s TacroType Test Adds Precision Medicine Angle To TMO Story - simplywall.st
The immortal life of Henrietta Lacks lawsuits gets a bit shorter with Novartis settlement - Fortune
Thermo Fisher Scientific Inc Stock (TMO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):